Literature DB >> 4795906

Prophylaxis of spontaneously developing mammary carcinoma in C3H-HeJ female mice by suppression of prolactin.

C W Welsch, C Gribler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4795906

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  15 in total

1.  Dedication: Clifford W. Welsch.

Authors:  D Medina; C Ip
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

Review 2.  Prolactin as an autocrine/paracrine factor in breast tissue.

Authors:  C V Clevenger; T L Plank
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

Review 3.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

Review 4.  Breast Cancer and Prolactin - New Mechanisms and Models.

Authors:  Charles V Clevenger; Hallgeir Rui
Journal:  Endocrinology       Date:  2022-10-01       Impact factor: 5.051

Review 5.  Prolactin: The Third Hormone in Breast Cancer.

Authors:  Linda A Schuler; Kathleen A O'Leary
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

Review 6.  Transgenic models to study actions of prolactin in mammary neoplasia.

Authors:  Lisa M Arendt; Linda A Schuler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

7.  The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: a reappraisal.

Authors:  C W Welsch; M Goodrich-Smith; C K Brown; L Roth
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

8.  Prolactin effects on the dietary regulation of mouse mammary tumor virus proviral DNA expression.

Authors:  N Hamada; R W Engelman; Y Tomita; R F Chen; H Iwai; R A Good; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 9.  From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics.

Authors:  Charles V Clevenger; Jiamao Zheng; Elizabeth M Jablonski; Traci L Galbaugh; Feng Fang
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

10.  Influence of chronic treatment with 2-bromo-alpha-ergocryptine (CB-154) on the reproductive and lactational performance of the C3H/HeJ female mouse.

Authors:  C W Welsh; L K Morford
Journal:  Experientia       Date:  1974-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.